Washington — California's proposed $200 million electric vehicle incentive program will be limited to first-time buyers and require participating manufacturers to contribute matching incentives, the ...

(Bloomberg) --Builders are working on a plan for a massive program to develop “Trump Homes” that would address the US affordability crisis while allowing private capital to deploy many billions of ...

Kim Kardashian attends the "All's Fair" Disney+ Premiere at Maison de La Chimie on October 21, 2025 in Paris, France Kim Kardashian is upping the ante on her head-turning lingerie collection. With ...

Dolly Parton answers questions from First Lady Britainy Beshear and Gov. Andy Beshear at the Lyric Theater in Lexington, Ky., Aug. 27, 2024. Arden Barnes Dolly Parton’s Imagination Library will be ...

HAYS COUNTY, Texas (KXAN) — Keeping vulnerable people from sitting in a cell is how Hays County leaders bill the Jail-Based Competency Restoration (JBCR) Program approved Tuesday by Hays County ...

In the middle of the pandemic, an Orange County workplace expert introduced a pilot program in Southern California to help people with disabilities secure hands-on training for new jobs. Three years ...

In financial compliance, even small mismatches in data can have outsized consequences. Whether it's reviewing sanctions alerts, verifying customer names, or screening payments, organisations rely on ...

WASHINGTON — Target is ending its price matching policy that would match the sales price on products sold for less at competitors' stores. The longtime program will be ending July 28, the company said ...

CREATING NEW NON-CAREER, POLICY-ORIENTED EMPLOYEES IN THE FEDERAL GOVERNMENT: Today, President Donald J. Trump signed an Executive Order creating a new classification of non-career federal workers, ...

WASHINGTON – The Department of Homeland Security is ending its controversial Quiet Skies surveillance program for airline travelers, saying June 5 that since its existence, it has "failed to stop a ...

Serious infections in patients with CLL/SLL treated with combination venetoclax and obinutuzumab compared with those treated with zanubrutinib: A real-world study. This is an ASCO Meeting Abstract ...